Proteolytic processing is required for viral superantigen activity

doi:10.1084/jem.181.5.1899

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Park, C. G.
	Articles by Winslow, G. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Park, C. G.
	Articles by Winslow, G. M.


Social Bookmarking

	What's this?

ARTICLES

Proteolytic processing is required for viral superantigen activity

CG Park, MY Jung, Y Choi and GM Winslow
Rockefeller University, New York 10021, USA.

The mouse mammary tumor virus-7 superantigen (vSAG7) is proteolytically processed in B cells at as many as three positions. Proteolytic processing appears to be important for superantigen activity because a processed form of vSAG7 was predominant among those forms that were found to bind to major histocompatibility complex class II molecules. To determine the functional significance of proteolytic processing, a mutation was introduced in vSAG7 at one of the sites where proteolytic cleavage is thought to take place in B cells. Elimination of the putative processing site at position 171 abrogated detectable vSAG7 surface expression in B cells, indicating that proteolytic processing is required for vSAG7 function. Coexpression in insect cells of vSAG7 and furin, a proprotein-processing enzyme, also demonstrated that furin could process vSAG7 at position 171.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Azar, G. A., Sekaly, R.-P., Thibodeau, J. (2005). A Defective Viral Superantigen-Presenting Phenotype in HLA-DR Transfectants Is Corrected by CIITA. J. Immunol. 174: 7548-7557 [Abstract] [Full Text]
Bikoff, E. K., Wutz, G., Kenty, G. A., Koonce, C. H., Robertson, E. J. (2001). Relaxed DM Requirements During Class II Peptide Loading and CD4+ T Cell Maturation in BALB/c Mice. J. Immunol. 166: 5087-5098 [Abstract] [Full Text]
Reilly, M., Mix, D., Reilly, A. A., Yang Ye, X., Winslow, G. M. (2000). Intercellular Transfer of a Soluble Viral Superantigen. J. Virol. 74: 8262-8267 [Abstract] [Full Text]
Denis, F., Shoukry, N. H., Delcourt, M., Thibodeau, J., Labrecque, N., McGrath, H., Munzer, J. S., Seidah, N. G., Sékaly, R.-P. (2000). Alternative Proteolytic Processing of Mouse Mammary Tumor Virus Superantigens. J. Virol. 74: 3067-3073 [Abstract] [Full Text]
Baribaud, F., Maillard, I., Vacheron, S., Brocker, T., Diggelmann, H., Acha-Orbea, H. (1999). Role of Dendritic Cells in the Immune Response Induced by Mouse Mammary Tumor Virus Superantigen. J. Virol. 73: 8403-8410 [Abstract] [Full Text]
Grigg, M. E., McMahon, C. W., Morkowski, S., Rudensky, A. Y., Pullen, A. M. (1998). Mtv-1 Superantigen Trafficks Independently of Major Histocompatibility Complex Class II Directly to the B-Cell Surface by the Exocytic Pathway. J. Virol. 72: 2577-2588 [Abstract] [Full Text]